AU2002323787A1 - Spiro compounds - Google Patents

Spiro compounds

Info

Publication number: AU2002323787A1
Authority: AU; Australia
Prior art keywords: spiro compounds; spiro; compounds
Prior art date: 2001-08-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002323787A

Other versions

AU2002323787B2 (en

Inventor

Takehiro Fukami

Hiroyuki Kishino

Katsumasa Nonoshita

Takeshi Sagara

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MSD KK

Original Assignee

Banyu Phamaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-07

Filing date

2002-08-02

Publication date

2003-06-19

2002-08-02 Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd

2002-08-02 Priority claimed from PCT/JP2002/007922 external-priority patent/WO2003014083A1/en

2003-06-19 Publication of AU2002323787A1 publication Critical patent/AU2002323787A1/en

2008-04-24 Application granted granted Critical

2008-04-24 Publication of AU2002323787B2 publication Critical patent/AU2002323787B2/en

2022-08-02 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002323787A 2001-08-07 2002-08-02 Spiro compounds Ceased AU2002323787B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001-239567		2001-08-07
JP2001239567		2001-08-07
PCT/JP2002/007922 WO2003014083A1 (en)	2001-08-07	2002-08-02	Spiro compounds

Publications (2)

Publication Number	Publication Date
AU2002323787A1 true AU2002323787A1 (en)	2003-06-19
AU2002323787B2 AU2002323787B2 (en)	2008-04-24

Family

ID=19070298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002323787A Ceased AU2002323787B2 (en)	2001-08-07	2002-08-02	Spiro compounds

Country Status (18)

Country	Link
US (1)	US7205417B2 (en)
EP (1)	EP1415986B1 (en)
JP (1)	JP4341404B2 (en)
KR (1)	KR20040023731A (en)
CN (1)	CN1538956A (en)
AT (1)	ATE427935T1 (en)
AU (1)	AU2002323787B2 (en)
BR (1)	BR0211740A (en)
CA (1)	CA2456599A1 (en)
DE (1)	DE60231880D1 (en)
EA (1)	EA006964B1 (en)
HU (1)	HUP0401108A2 (en)
IL (1)	IL160139A0 (en)
MX (1)	MXPA04001144A (en)
NO (1)	NO20040534L (en)
PL (1)	PL367983A1 (en)
WO (1)	WO2003014083A1 (en)
ZA (1)	ZA200400091B (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6374762B1 (en) *	1997-10-27	2002-04-23	Correct Craft, Inc.	Water sport towing apparatus
ES2193875B2 (en) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS.
US20040242572A1 (en) *	2002-08-24	2004-12-02	Boehringer Ingelheim International Gmbh	New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
WO2004096139A2 (en)	2003-04-24	2004-11-11	Incyte Corporation	Aza spiro alkane derivatives as inhibitors of metalloproteases
EP1734963A4 (en)	2004-04-02	2008-06-18	Merck & Co Inc	METHOD FOR TREATING MEN WITH METABOLIC AND ANTHROPOMETRIC DISORDERS
CN101080226A (en) *	2004-08-10	2007-11-28	因塞特公司	Amido compounds and their use as pharmaceuticals
US7786141B2 (en) *	2004-08-19	2010-08-31	Vertex Pharmaceuticals Incorporated	Dihydrospiroindene modulators of muscarinic receptors
JP2008510728A (en) *	2004-08-19	2008-04-10	バーテックスファーマシューティカルズインコーポレイテッド	Muscarinic receptor modulators
AU2005280921B2 (en) *	2004-09-07	2011-05-19	Msd K.K.	Carbamoyl-substituted spiro derivative
US7863449B2 (en) *	2004-11-29	2011-01-04	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
KR20080048502A (en)	2005-09-29	2008-06-02	머크 앤드 캄파니 인코포레이티드	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
UA94433C2 (en) *	2005-11-10	2011-05-10	Баниу Фармасьютикал Ко., Лтд.	Aza-substituted spiro derivative
NZ568292A (en)	2005-11-10	2011-08-26	Msd Kk	Spiro[cyclohexane-1,1'-(3'H)-4'-azaisobenzofuran]-4-carboxamide derivatives
RU2008130094A (en) *	2005-12-22	2010-01-27	Вертекс Фармасьютикалз Инкорпорейтед (Us)	MUSCARINE RECEPTOR MODULATORS
EP1988892A2 (en)	2006-02-22	2008-11-12	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
ATE517106T1 (en)	2006-02-22	2011-08-15	Vertex Pharma	CONDENSED SPIROPIPERIDINE AS MODULATORS OF MUSCARINOUS RECEPTORS
WO2007143600A2 (en)	2006-06-05	2007-12-13	Incyte Corporation	Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
CN101500565A (en) *	2006-06-29	2009-08-05	弗特克斯药品有限公司	Modulators of muscarinic receptors
EP2051712A2 (en) *	2006-08-15	2009-04-29	Vertex Pharmceuticals Incorporated	Modulators of muscarinic receptors
JP2010501561A (en) *	2006-08-18	2010-01-21	バーテックスファーマシューティカルズインコーポレイテッド	Modulator of muscarinic receptor
AU2007300627B2 (en)	2006-09-22	2012-02-16	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
JP5319518B2 (en)	2007-04-02	2013-10-16	Ｍｓｄ株式会社	Indoledione derivative
JP5546451B2 (en)	2007-06-04	2014-07-09	シナジーファーマシューティカルズインコーポレイテッド	Agonyl cyclase agonists useful in the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en)	2008-06-04	2010-05-13	Synergy Pharmaceuticals, Inc.	Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009045519A1 (en) *	2007-10-03	2009-04-09	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
CA2716128A1 (en) *	2008-02-27	2009-09-03	Vitae Pharmaceuticals, Inc.	Inhibitors of 11.beta.-hydroxysteroid dehydrogenase type 1
EP3241839B1 (en)	2008-07-16	2019-09-04	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2348857B1 (en)	2008-10-22	2016-02-24	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2350010B1 (en)	2008-10-30	2014-03-26	Merck Sharp & Dohme Corp.	Isonicotinamide orexin receptor antagonists
AU2009309037A1 (en)	2008-10-31	2010-05-06	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2011069298A1 (en) *	2009-12-11	2011-06-16	F. Hoffmann-La Roche Ag	Novel cyclopropane indolinone derivatives
CN102656147A (en) *	2009-12-11	2012-09-05	霍夫曼-拉罗奇有限公司	Spiro indole-cyclopropane indolinones useful as AMPK modulators
US8895596B2 (en)	2010-02-25	2014-11-25	Merck Sharp & Dohme Corp	Cyclic benzimidazole derivatives useful as anti-diabetic agents
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
US8754114B2 (en)	2010-12-22	2014-06-17	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
MY159058A (en)	2011-02-25	2016-12-15	Merck Sharp & Dohme	Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agent
AR088352A1 (en)	2011-10-19	2014-05-28	Merck Sharp & Dohme	ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE
JP2015520752A (en)	2012-05-11	2015-07-23	アッヴィ・インコーポレイテッド	Pyridazine and pyridine derivatives as NAMPT inhibitors
PE20190736A1 (en)	2012-06-13	2019-05-23	Incyte Holdings Corp	TRICICLIC COMPOUNDS REPLACED AS INHIBITORS OF THE RECEIVER OF THE FIBROBLAST GROWTH FACTOR (FGFR)
EP2880028B1 (en)	2012-08-02	2020-09-30	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
WO2014026125A1 (en)	2012-08-10	2014-02-13	Incyte Corporation	Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
JP2016516004A (en)	2013-02-22	2016-06-02	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	Antidiabetic bicyclic compound
WO2014139388A1 (en)	2013-03-14	2014-09-18	Merck Sharp & Dohme Corp.	Novel indole derivatives useful as anti-diabetic agents
HK1220696A1 (en)	2013-03-15	2017-05-12	Bausch Health Ireland Limited	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
KR102269032B1 (en)	2013-04-19	2021-06-24	인사이트 홀딩스 코포레이션	Bicyclic heterocycles as fgfr inhibitors
EP4424697A3 (en)	2013-06-05	2024-12-25	Bausch Health Ireland Limited	Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2015051496A1 (en)	2013-10-08	2015-04-16	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
ES2895769T3 (en)	2015-02-20	2022-02-22	Incyte Corp	Bicyclic heterocycles as FGFR inhibitors
MA41551A (en)	2015-02-20	2017-12-26	Incyte Corp	BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
US9580423B2 (en)	2015-02-20	2017-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
US11072602B2 (en)	2016-12-06	2021-07-27	Merck Sharp & Dohme Corp.	Antidiabetic heterocyclic compounds
US10968232B2 (en)	2016-12-20	2021-04-06	Merck Sharp & Dohme Corp.	Antidiabetic spirochroman compounds
AR111960A1 (en)	2017-05-26	2019-09-04	Incyte Corp	CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION
SG11202010882XA (en)	2018-05-04	2020-11-27	Incyte Corp	Salts of an fgfr inhibitor
SI3788047T1 (en)	2018-05-04	2024-11-29	Incyte Corporation	Solid forms of an fgfr inhibitor and processes for preparing the same
US11098029B2 (en)	2019-02-13	2021-08-24	Merck Sharp & Dohme Corp.	5-alkyl pyrrolidine orexin receptor agonists
EP3923933A4 (en)	2019-02-13	2022-08-17	Merck Sharp & Dohme Corp.	PYRROLIDINE-LIKE OREXIN RECEPTOR AGONISTS
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
EP4010314B1 (en)	2019-08-08	2024-02-28	Merck Sharp & Dohme LLC	Heteroaryl pyrrolidine and piperidine orexin receptor agonists
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
US11607416B2 (en)	2019-10-14	2023-03-21	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
US11566028B2 (en)	2019-10-16	2023-01-31	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2021113462A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Derivatives of an fgfr inhibitor
EP4069696A1 (en)	2019-12-04	2022-10-12	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CN116249697A (en)	2020-08-18	2023-06-09	默沙东有限责任公司	Dicyclopyrrolidine orexin receptor agonist
CN112939864B (en) *	2021-01-29	2022-05-06	中国医科大学	Spiro[benzo[c]azepin-1,1'-cyclohexyl]-3-ones
WO2022221170A1 (en)	2021-04-12	2022-10-20	Incyte Corporation	Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
WO2022261159A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
WO2022261160A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2311523A (en)	1996-03-25	1997-10-01	Merck & Co Inc	Tryptophan urea tachykinin receptor antagonists
US5869489A (en) *	1996-03-25	1999-02-09	Merck & Co., Inc.	Trypthophan ureas as neurokinnin antagonists
WO1999022735A1 (en)	1997-10-30	1999-05-14	Merck & Co., Inc.	Somatostatin agonists
DE69929235T2 (en)	1998-11-10	2006-08-24	Merck & Co., Inc.	SPIRO INDOLE AS Y5 RECEPTOR ANTAGONISTS
US6803372B2 (en) *	1999-08-20	2004-10-12	Banyu Pharmaceutical Co., Ltd.	Spiro compounds
AU6909300A (en)	1999-08-20	2001-03-19	Merck & Co., Inc.	Substituted ureas as cell adhesion inhibitors
TWI279402B (en) *	1999-08-20	2007-04-21	Banyu Pharma Co Ltd	Spiro compounds having NPY antagonistic activities and agents containing the same
JPWO2002022563A1 (en) *	2000-09-14	2004-01-22	東レ株式会社	Urea derivative and adhesive molecule inhibitor containing the same as active ingredient
MXPA03004245A (en)	2000-12-12	2003-09-22	Neurogen Corp	Spiro[isobenzofuran-1,4 -piperidin]-3-ones and 3h-spiroisobenzofuran-1, 4 -piperidines.
CA2454228C (en) *	2001-07-24	2011-03-22	Merck & Co., Inc.	Radiolabeled neuropeptide y y5 receptor antagonists

2002
- 2002-08-02 PL PL02367983A patent/PL367983A1/en not_active Application Discontinuation
- 2002-08-02 KR KR10-2004-7001947A patent/KR20040023731A/en not_active Withdrawn
- 2002-08-02 JP JP2003519033A patent/JP4341404B2/en not_active Expired - Fee Related
- 2002-08-02 EA EA200400288A patent/EA006964B1/en not_active IP Right Cessation
- 2002-08-02 DE DE60231880T patent/DE60231880D1/en not_active Expired - Lifetime
- 2002-08-02 BR BR0211740-1A patent/BR0211740A/en not_active IP Right Cessation
- 2002-08-02 AU AU2002323787A patent/AU2002323787B2/en not_active Ceased
- 2002-08-02 MX MXPA04001144A patent/MXPA04001144A/en unknown
- 2002-08-02 US US10/485,955 patent/US7205417B2/en not_active Expired - Fee Related
- 2002-08-02 EP EP02755790A patent/EP1415986B1/en not_active Expired - Lifetime
- 2002-08-02 AT AT02755790T patent/ATE427935T1/en not_active IP Right Cessation
- 2002-08-02 WO PCT/JP2002/007922 patent/WO2003014083A1/en not_active Ceased
- 2002-08-02 CN CNA028153073A patent/CN1538956A/en active Pending
- 2002-08-02 HU HU0401108A patent/HUP0401108A2/en unknown
- 2002-08-02 IL IL16013902A patent/IL160139A0/en unknown
- 2002-08-02 CA CA002456599A patent/CA2456599A1/en not_active Abandoned
2004
- 2004-01-07 ZA ZA200400091A patent/ZA200400091B/en unknown
- 2004-02-05 NO NO20040534A patent/NO20040534L/en not_active Application Discontinuation

Publication	Publication Date	Title
AU2002323787A1 (en)	2003-06-19	Spiro compounds
AU2002349297A1 (en)	2003-06-17	Statin-like compounds
AU2001252574A1 (en)	2002-01-31	Novel bicyclic compounds
AU2002360508A1 (en)	2003-06-23	Substituted hydroxyethylamines
AU2002253675A1 (en)	2003-05-01	Chromene compound
AU2002352221A1 (en)	2003-06-30	Bicyclic n-arylamides
AU2002359165A1 (en)	2003-06-30	Novel compounds
AU2002336311A1 (en)	2003-07-03	Bicyclic compound
AU2002308154A1 (en)	2002-11-11	Triazolopyrimidines
AU2002349677A1 (en)	2003-07-24	Chromene compound
AUPR878201A0 (en)	2001-12-06	New compounds
AU2002251024A1 (en)	2003-03-20	Substituted fluoroalcoxyphenylsulfonylurea
AUPR362001A0 (en)	2001-04-05	New compound
AU2001288110A1 (en)	2002-04-08	Spiro compounds
AU2002321215A1 (en)	2003-05-22	Substituted 4-aminocyclohexanols
AU2002359761A1 (en)	2003-06-30	Antibiotic compounds
AUPR920301A0 (en)	2001-12-20	Neurologically-active compounds
AU2004201666B2 (en)	2006-03-23	4-Imidazolin-2-one compounds
AU2002346861A1 (en)	2003-05-12	Substituted 1h-quinolin-2-one compounds
AU2002306300A1 (en)	2003-03-03	Azasugar compounds
AU2002235881A1 (en)	2002-08-19	Compounds
AU2002337136A1 (en)	2003-04-22	Isocyanato-isocyano compounds
AU2002363108A1 (en)	2003-05-06	4-imidazolin-2-one compounds
AU2002341486A1 (en)	2003-04-14	Novel compounds
AU2002302528A1 (en)	2002-10-28	Novel compounds